# Edoxaban

## Lixiana F.C. 30mg

| TAH Drug Code      | [OLIX](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OLIX)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Deep vein thrombosis and pulmonary embolism: Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5 to 10 days of initial therapy with a parenteral anticoagulant. Nonvalvular atrial fibrillation: To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Prevent stroke and systemic embolism: oral 60mg once daily.  Treatment of DVT and PE: oral 60mg once daily after at least 5 days of parenteral anticoagulant therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | ‧ Hypersensitivity to the active ingredient or any excipient. ‧ Clinically significant active bleeding. ‧ Liver disease associated with coagulopathy and a clinically relevant bleeding risk. ‧ Presence of lesions or conditions considered to carry a significant risk of major bleeding， which may include: current or recent gastrointestinal ulceration， malignant tumors with high bleeding risk， recent brain or spinal injury， recent brain， spinal， or ophthalmic surgery， recent intracranial hemorrhage， known or suspected esophageal varices， arteriovenous malformations， aneurysms， or major intra-spinal or intracerebral vascular abnormalities. ‧ Uncontrolled severe hypertension. ‧ Concomitant use of any other anticoagulant therapy， such as unfractionated heparin (UFH)， low molecular weight heparins (e.g.， enoxaparin， dalteparin)， heparin derivatives (e.g.， fondaparinux)， or oral anticoagulants (e.g.， warfarin， dabigatran etexilate， rivaroxaban， apixaban)， except under the following conditions: transitioning to or from oral anticoagulant therapy， or when UFH is used at doses necessary to maintain the patency of a central venous or arterial catheter. ‧ Pregnancy and breastfeeding. ‧ Patients with end-stage renal disease (ESRD) (CrCl < 15 mL/min) or those undergoing dialysis are not recommended to use Lixiana. |
| Adverse Effects    | >10%: Hematologic and oncologic: Hemorrhage (22%) 1% to 10%: Dermatologic: Dermal hemorrhage (6%)， skin rash (4%) Gastrointestinal: Gastrointestinal hemorrhage (4%)， lower GI bleeding (3%) Genitourinary: Vaginal hemorrhage (9%)， gross hematuria， urethral bleeding Hematologic and oncologic: Major hemorrhage， nonlife-threatening (7% to 9%; noncritical organ: 1%; critical organ: <1%)， major hemorrhage (1%)， oral hemorrhage (3%)， anemia (2%)， decreased hemoglobin (1%)， puncture site bleeding (1%) Hepatic: Abnormal hepatic function tests (5% to 8%) Respiratory: Epistaxis (5%)， pharyngeal bleeding                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/edoxaban-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

